- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Big Green Snowflakes
Global Pharmaceuticals & Biotech Big Green Snowflakes
Results
3050
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
3050 companies
GenSight Biologics
Market Cap: €23.4m
A clinical-stage biotechnology company, discovers, develops, and commercializes novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.
SIGHT
€0.15
7D
-2.3%
1Y
-59.3%
Kyverna Therapeutics
Market Cap: US$177.3m
Kyverna Therapeutics, Inc., clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases.
KYTX
US$4.02
7D
8.1%
1Y
-42.5%
SOL Global Investments
Market Cap: CA$12.6m
A private equity firm specializing in emerging growth.
SOL
CA$0.05
7D
-9.1%
1Y
42.9%
Cellectis
Market Cap: €187.3m
A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.
ALCLS
€2.59
7D
16.1%
1Y
25.7%
SkinBioTherapeutics
Market Cap: UK£40.1m
A life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally.
SBTX
UK£0.15
7D
5.1%
1Y
30.5%
GH Research
Market Cap: US$832.4m
Together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States.
GHRS
US$12.89
7D
-8.1%
1Y
58.4%
Ascendis Pharma
Market Cap: US$12.3b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.
ASND
US$198.46
7D
-0.8%
1Y
75.7%
ARS Pharmaceuticals
Market Cap: US$1.0b
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.
SPRY
US$10.50
7D
-3.5%
1Y
-12.5%
Atai Life Sciences
Market Cap: US$1.0b
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.
ATAI
US$4.72
7D
4.4%
1Y
277.6%
Dianthus Therapeutics
Market Cap: US$1.1b
A clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases.
DNTH
US$37.90
7D
56.2%
1Y
37.5%
BioLife Solutions
Market Cap: US$1.3b
Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.
BLFS
US$26.49
7D
5.8%
1Y
14.2%
Protara Therapeutics
Market Cap: US$120.0m
A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.
TARA
US$3.11
7D
-3.7%
1Y
82.9%
Arcus Biosciences
Market Cap: US$1.2b
A clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States.
RCUS
US$11.72
7D
0.7%
1Y
-30.9%
Amylyx Pharmaceuticals
Market Cap: US$937.1m
A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.
AMLX
US$11.83
7D
20.2%
1Y
360.3%
Curaleaf Holdings
Market Cap: CA$3.3b
Produces and distributes cannabis products in the United States and internationally.
CURA
CA$3.95
7D
3.7%
1Y
2.9%
TC Biopharm (Holdings)
Market Cap: US$424.8k
A clinical-stage biopharmaceutical company, develops immunotherapy products based on its allogeneic gamma delta T cell platform in the United States.
TCBP.Y
US$0.22
7D
-28.5%
1Y
-99.7%
Organon
Market Cap: US$2.7b
Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.
OGN
US$10.26
7D
4.4%
1Y
-49.1%
Passage Bio
Market Cap: US$22.3m
A genetic medicines company, develops gene therapies for central nervous system diseases.
PASG
US$7.06
7D
-0.9%
1Y
-53.9%
Curasight
Market Cap: DKK 264.2m
Develops therapeutic and diagnostic solutions for the treatment of cancer.
CURAS
DKK 5.76
7D
-11.4%
1Y
-45.9%
Vaxcyte
Market Cap: US$4.2b
A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.
PCVX
US$32.00
7D
-0.3%
1Y
-71.8%
Monopar Therapeutics
Market Cap: US$277.2m
A clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.
MNPR
US$42.90
7D
18.5%
1Y
1,687.5%
Cue Biopharma
Market Cap: US$59.2m
A clinical-stage biopharmaceutical company, develops a novel class of injectable therapeutics to selectively engage and modulate targeted, disease relevant T cells in the United States.
CUE
US$0.76
7D
-3.9%
1Y
29.3%
Revolution Medicines
Market Cap: US$7.7b
A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.
RVMD
US$40.45
7D
1.7%
1Y
-2.9%
Centessa Pharmaceuticals
Market Cap: US$2.8b
A clinical-stage pharmaceutical company, discovers, develops, and delivers medicines.
CNTA
US$22.71
7D
42.7%
1Y
65.2%
Lavipharm
Market Cap: €133.9m
Engages in the research, development, manufacture, import, marketing, sale, and wholesale of pharmaceutical, cosmetics, and healthcare products to physicians and pharmacists in Greece and internationally.
LAVI
€0.79
7D
-2.6%
1Y
0.1%
Cellectar Biosciences
Market Cap: US$16.9m
A clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.
CLRB
US$5.00
7D
4.6%
1Y
-92.0%
Tchaikapharma High Quality Medicines AD
Market Cap: лв1.6b
Develops, manufactures, and sells medicines in Bulgaria.
THQM
лв16.90
7D
-1.2%
1Y
2.1%
InMed Pharmaceuticals
Market Cap: US$4.5m
A clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States.
INM
US$2.17
7D
2.8%
1Y
-62.6%
Lantern Pharma
Market Cap: US$43.7m
Focuses on the discovery and development of oncology drug.
LTRN
US$3.96
7D
-7.7%
1Y
6.5%
Tempest Therapeutics
Market Cap: US$48.8m
A clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer.
TPST
US$10.51
7D
0.05%
1Y
-41.4%
Xlife Sciences
Market Cap: CHF 124.0m
Focuses on the development and commercialization of research projects in the life sciences sector.
XLS
CHF 21.50
7D
0.9%
1Y
-23.2%
Tilray Brands
Market Cap: US$1.3b
A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.
TLRY
US$1.09
7D
-8.0%
1Y
-36.6%
S.C. Sintofarm
Market Cap: RON 16.6m
Develops pharmaceutical products in Romania.
SINT
RON 4.30
7D
0%
1Y
-21.8%
Hansoh Pharmaceutical Group
Market Cap: HK$233.6b
An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.
3692
HK$38.58
7D
3.8%
1Y
102.4%
Navana Pharmaceuticals
Market Cap: ৳6.3b
Engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh.
NAVANAPHAR
৳59.10
7D
-5.1%
1Y
-10.9%
Morepen Laboratories
Market Cap: ₹29.3b
Develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally.
500288
₹53.54
7D
7.2%
1Y
-43.5%